In silico model of the spectrum of reactivity to mycobacteria

M. Amicosante, E. Puxeddu, M. Pallante, A. Comandini, C. Saltini (Rome, Italy)

Source: Annual Congress 2010 - Clinical tuberculosis
Session: Clinical tuberculosis
Session type: Thematic Poster Session
Number: 3191
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Amicosante, E. Puxeddu, M. Pallante, A. Comandini, C. Saltini (Rome, Italy). In silico model of the spectrum of reactivity to mycobacteria. Eur Respir J 2010; 36: Suppl. 54, 3191

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017


Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017
Year: 2017



A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis: contribution of murine studies
Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020
Year: 2021



Investigation and functional enrichment analysis of the human gene interaction network with common gram-negative respiratory pathogens predicts possible association with lung adenocarcinoma.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019

Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020

Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012


Breathprinting of multiple bacterial lung pathogens in vitro and in mice: what we can learn from translational approaches
Source: International Congress 2014 – Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases
Year: 2014



A new mathematical model to identify contacts with recent and remote latent tuberculosis
Source: ERJ Open Res, 5 (2) 00078-2019; 10.1183/23120541.00078-2019
Year: 2019



High-resolution quantitative proteomics applied to the discovery of biomarkers of innate immune response in tuberculosis.
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012


Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Comparison of Mycobacterium tuberculosis drug susceptibility tests by nucleic acid amplification and classic technique
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001

Deficient in silico selection of Mycobacterium tuberculosis epitopes by an HLA susceptible allele
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005


In vitro immune response to Mycobacterium tuberculosis antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005

A fully molecular drug sensitivity pattern for M.tuberculosis complex: what is available today and what is in the pipeline
Source: International Congress 2017 – How to manage difficult tuberculosis cases: diagnosis and treatment
Year: 2017